| 20th Oct 2021 2:29 pm |
RNS |
Scheme of arrangement |
| 20th Oct 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 20th Oct 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th Oct 2021 2:01 pm |
RNS |
Capital Reorganisation |
| 6th Oct 2021 3:19 pm |
RNS |
Director/PDMR Shareholding |
| 5th Oct 2021 7:00 am |
RNS |
Director/PDMR Dealing |
| 4th Oct 2021 8:06 am |
RNS |
PDMR Dealing |
| 28th Sep 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Sep 2021 5:16 pm |
RNS |
Result of Meeting |
| 27th Sep 2021 5:11 pm |
RNS |
Result of Meeting |
| 24th Sep 2021 5:49 pm |
RNS |
Half-year Report |
| 20th Sep 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 20th Sep 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 20th Sep 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 20th Sep 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 7th Sep 2021 6:00 pm |
RNS |
Change of Registered Office |
| 7th Sep 2021 7:00 am |
RNS |
TLSA to Host Call to Discuss Exclusive License |
| 3rd Sep 2021 5:00 pm |
RNS |
Posting of Scheme Document and Notice of Meetings |
| 3rd Sep 2021 7:00 am |
RNS |
Posting of Scheme Document and Notice of Meetings |
| 2nd Sep 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 2nd Sep 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 2nd Sep 2021 7:00 am |
RNS |
License Agreement to Evaluate Foralumab with CAR T |
| 20th Aug 2021 7:00 am |
RNS |
TiLS files scheme for a corporate reorganisation |
| 17th Aug 2021 7:00 am |
RNS |
Article Publication on Foralumab in COVID Patients |
| 16th Aug 2021 6:11 pm |
RNS |
TLSA to Present at the Q3 Virtual Investor Summit |
| 3rd Aug 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 3rd Aug 2021 4:35 pm |
RNS |
Price Monitoring Extension |
| 8th Jul 2021 12:19 pm |
RNS |
ADS Ex-Dividend Date Scheduled for July, 09 2021 |
| 2nd Jul 2021 12:30 pm |
RNS |
Distribution Dates for shares and ADRs in Accustem |
| 2nd Jul 2021 12:30 pm |
RNS |
Distribution Dates: shares and ADRs in Accustem |
| 30th Jun 2021 11:36 am |
RNS |
Dr Howard Weiner on Bloomberg at 1.50pm ET today |
| 25th Jun 2021 10:40 am |
RNS |
Result of Annual General Meeting |
| 23rd Jun 2021 7:00 am |
RNS |
P2 Trial with foralumab on Severe COVID19 Patients |
| 21st Jun 2021 7:08 am |
RNS |
Appointment of VP of Regulatory Affairs |
| 17th Jun 2021 7:00 am |
RNS |
Tiziana Applies for Grant from UK-CTAP |
| 2nd Jun 2021 7:00 am |
RNS |
Notice of AGM |
| 26th May 2021 7:00 am |
RNS |
Significant Immunomodulation effects on Biomarkers |
| 25th May 2021 7:00 am |
RNS |
Trial Initiation in a SPMS Patient with Foralumab |
| 21st May 2021 7:00 am |
RNS |
Director/PDMR Dealing |
| 18th May 2021 12:18 pm |
RNS |
Amended - Final Results |
